Establishing the Wholesale Division as a New Core Business
First written in FY2016. 18 of 35 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-05.
No other company in this theme has enough history to compare yet.
- FY2026WorsenedAnnual report
「Segment profit or loss (△), Wholesale Division: △22,058」
The Wholesale Division's segment loss widened from ¥7.31 million in the previous fiscal year to ¥22.058 million. - FY2026-H1WorsenedAnnual report
「Segment profit or loss (△), Wholesale Division: △13,271」
Wholesale Division segment profit swung from a profit of ¥21.382 million in the same period of the previous year to a loss of ¥13.271 million, indicating deterioration in profitability toward developing the division into a core business. - FY2025WorsenedAnnual report
「As a result, revenue was ¥5,585 million, up 3.1% from the same period of the previous year, and segment profit was ¥23 million, down 59.4% year on year.」
Although the household pharmaceuticals and other products sales business posted higher revenue, segment profit declined 59.4% year on year, indicating deterioration in profitability as the core business, including the Wholesale Division, was developed. - FY2025-H1WorsenedAnnual report
「As a result, revenue was ¥2,793 million, up 2.0% from the same period of the previous year, while the segment recorded a loss of ¥40 million, compared with segment profit of ¥2 million in the same period of the previous year.」
Although the household pharmaceuticals and other products sales business as a whole posted higher revenue, segment profit swung from a profit in the same period of the previous year to a loss of ¥40 million. - FY2024AdvancedAnnual report
「In the Wholesale Division, we worked to acquire and expand other companies' store private-label products. We also focused on the EC business (online retail business) to build a stable earnings base. As a result, revenue was ¥5,419 million, up 8.3% from the same period of the previous year, and segment profit was ¥58 million, up 74.7% year on year.」
The company advanced store private-label products and the EC business, resulting in higher revenue and profit for the household pharmaceuticals and other products sales business as a whole. - FY2024-Q3AdvancedAnnual report
「In the Wholesale Division, we were able to continue selling beverages such as bottled water. In particular, we promoted planning and sales of OEM (private-label) beverages for other companies and expanded the range of products.」
The Wholesale Division advanced sales of beverages and OEM products, generating revenue of ¥1,160.673 million and segment profit of ¥18.375 million. - FY2024-Q2AdvancedAnnual report
「In the Wholesale Division, the continued hot weather enabled ongoing sales of beverages such as bottled water. We also sold heatstroke-prevention products and other items. In particular, we promoted planning and sales of OEM (private-label) beverages for other companies and expanded the range of products. We also further strengthened the online retail business and worked to improve profitability. As a result, revenue was ¥2,738 million, up 10.9% from the same period of the previous year, and segment profit was ¥2 million, down 73.4% year on year.」
Although beverages, heatstroke-prevention products, OEM products and online retail expanded, the household pharmaceuticals and other products sales business as a whole posted higher revenue while segment profit declined 73.4% year on year. - FY2024-Q1WorsenedAnnual report
「Revenue from external customers, Wholesale Division: 409,421; segment profit, Wholesale Division: 8,152」
Although the Wholesale Division posted higher revenue, segment profit declined from ¥15.859 million in the same period of the previous year to ¥8.152 million, indicating deterioration in profitability as a new core business. - FY2023WorsenedAnnual report
「As a result, revenue was ¥5,002 million, up 6.8% from the same period of the previous year, and segment profit was ¥33 million, down 45.9% year on year.」
Although the household pharmaceuticals and other products sales business posted higher revenue, segment profit declined 45.9% year on year, indicating deterioration in profitability as the core business, including the Wholesale Division, was developed. - FY2023-Q3AdvancedAnnual report
「In the Wholesale Division, awareness of infection prevention continued to increase, and we sold high-performance masks and two-tone masks. We also actively sold beverages and food products under other companies' OEM (private-label) arrangements. As a result, revenue was ¥3,956 million, up 7.3% from the same period of the previous year, and segment profit was ¥175 million, up 28.1% year on year.」
Under the policy of establishing the Wholesale Division as a new core business, the company advanced sales of masks and OEM products, resulting in higher revenue and profit for the household pharmaceuticals and other products sales business as a whole. - FY2023-Q2WorsenedAnnual report
「In the Wholesale Division, awareness of infection prevention continued to increase, and we continued selling high-performance masks and summer masks. Sales of beverages and food products under other companies' OEM (private-label) arrangements also contributed to higher revenue.」
Although product sales and OEM sales resulted in higher revenue, Wholesale Division segment profit declined from ¥10.487 million in the same period of the previous year to ¥7.7 million, indicating deterioration in profitability toward developing the division into a new core business. - FY2023-Q1AdvancedAnnual report
「In the Wholesale Division, although awareness of infection prevention increased, we continued selling disinfecting and alcohol products and summer masks. Sales of beverages under other companies' OEM (private-label) arrangements also contributed to higher revenue.」
The Wholesale Division sold disinfecting and alcohol products, summer masks and OEM beverages, generating revenue of ¥261.282 million and segment profit of ¥15.859 million. The division swung from a segment loss in the same period of the previous year to profit. - FY2022WorsenedAnnual report
「As a result, revenue was ¥4,686 million, down 8.2% from the same period of the previous year, and segment profit was ¥61 million, down 64.7% year on year.」
While the policy of establishing the Wholesale Division as a new core business continues, revenue and segment profit for the household pharmaceuticals and other products sales business as a whole declined substantially. - FY2022-Q3WorsenedAnnual report
「However, in the household pharmaceuticals and other products sales business, although customers' awareness of infection prevention increased from the previous fiscal year, shortages of disinfecting alcohol products, masks and other items were resolved, while the number of units sold declined year on year, resulting in lower revenue and segment profit. As a result, revenue was ¥3,686 million, down 11.5% from the same period of the previous year, and segment profit was ¥136 million, down 57.4% year on year.」
Revenue in the household pharmaceuticals and other products sales business was ¥3,686 million and segment profit was ¥136 million, both below the same period of the previous year. Profitability continues to deteriorate relative to the goal of establishing the Wholesale Division as a new core business. - FY2022-Q2WorsenedAnnual report
「However, in the household medicines and other sales business, although customers' awareness of infection prevention had increased from the previous period, sales and segment profit declined because shortages of disinfectant alcohol products, masks and other items had been resolved and orders were expected to be deferred. As a result, revenue was ¥2,302 million, down 11.7% year on year, and segment profit was ¥9 million, down 87.5% year on year.」
The household pharmaceuticals and other products sales business, including the Wholesale Division, posted lower revenue and profit, with profitability deteriorating as a new core business. - FY2022-Q1WorsenedAnnual report
「Segment profit or loss (△), Wholesale Division: △146」
Wholesale Division segment profit swung from ¥17.516 million in the same period of the previous year to a loss of ¥146 thousand, indicating deterioration in profitability against the goal of establishing the division as a new core business. - FY2021AdvancedAnnual report
「Revenue from external customers, Wholesale Division: 986,799; segment profit: 143,295」
Revenue in the Wholesale Division was ¥986.799 million and segment profit was ¥143.295 million, up from revenue of ¥663.466 million and profit of ¥71.446 million in the previous fiscal year. The company describes operational progress as a new core business. - FY2021-Q3AdvancedAnnual report
「For revenue in the Wholesale Division, we worked to ensure a stable supply of year-round and seasonal regular products as part of efforts to strengthen the business platform. Revenue from external customers, Wholesale Division: 851,778; segment profit, Wholesale Division: 150,762」
The company worked to ensure a stable supply of regular products, resulting in Wholesale Division revenue of ¥851.778 million and segment profit of ¥150.762 million. The company describes operational progress toward developing the Wholesale Division into a core business. - FY2021-Q2AdvancedAnnual report
「For revenue in the Wholesale Division, we worked to ensure a stable supply of year-round and seasonal regular products as part of efforts to strengthen the business platform. Sales of disinfecting and deodorizing products, including the summer-use contact-cooling "Cool Fit Mask," were strong due to increased awareness of infection prevention amid the spread of the novel coronavirus and demand for masks. As a result, revenue was ¥2,607 million, up 23.7% from the same period of the previous year, and segment profit was ¥74 million, compared with a segment loss of ¥92 million in the same period of the previous year.」
The Wholesale Division posted higher revenue on the stable supply of regular products and strong sales of disinfecting and deodorizing products, and swung from a segment loss in the same period of the previous year to profit of ¥74 million. - FY2021-Q1AdvancedAnnual report
「For revenue in the Wholesale Division, we worked to ensure a stable supply of year-round and seasonal regular products as part of efforts to strengthen the business platform. In addition, sales of disinfecting and deodorizing products remained firm as awareness of infection prevention increased amid the spread of the novel coronavirus. As a result, revenue was ¥1,273 million, up 12.8% from the same period of the previous year, and segment profit was ¥71 million, compared with a segment loss of ¥4 million in the same period of the previous year.」
The Wholesale Division posted higher revenue on the stable supply of regular products and sales of disinfecting and deodorizing products, and swung from a loss in the same period of the previous year to profit of ¥71 million. - FY2020AdvancedAnnual report
「Revenue from external customers, Wholesale Division: 663,466; segment profit or loss (△), Wholesale Division: 71,446」
Revenue in the Wholesale Division was ¥663 million and segment profit was ¥71 million, up from segment profit of ¥37 million in the previous fiscal year. The company describes operational progress toward developing the Wholesale Division into a core business. - FY2020-Q3RestatedAnnual report
「In the Wholesale Division, sales and shipments of disinfecting and deodorizing products began.」
The company continues to describe the start of sales and shipments of disinfecting and deodorizing products as part of the division's development into a core business. - FY2020-Q2AdvancedAnnual report
「In the Wholesale Division, sales of carbonated water increased, while sales of disinfecting and deodorizing products and the rollout of the new product "Air Mask Tablock Plus" also began.」
In addition to increased sales of carbonated water and disinfecting and deodorizing products, the company began rolling out the new product "Air Mask Tablock Plus." Specific product expansion is progressing toward developing the Wholesale Division into a core business. - FY2019-Q3AdvancedAnnual report
「Sales and shipments of new disinfecting and deodorizing products, including "Air Mask Name Holder" and "Air Mask Spare & Pocket," also began at major mass retailers, drugstores and other outlets.」
Sales and shipments of a new range of disinfecting and deodorizing products began at major mass retailers, drugstores and other outlets. - FY2019-Q2AdvancedAnnual report
「In the wholesale segment, wholesale sales to 紀州中京医薬品, with which the company newly concluded a franchise agreement, have increased. In addition, sales of products related to disinfecting and deodorizing agents began in September.」
Sales to new franchise partners of 紀州中京医薬品 increased, and sales of products related to disinfecting and deodorizing agents also began. - FY2018WorsenedAnnual report
「Although the number of stores carrying the disinfecting and deodorizing products increased at major mass retailers, drugstores and other outlets, beverage sales declined. As a result, revenue was ¥4,865 million, down 7.2% year on year, and the segment recorded a loss of ¥8 million, compared with segment profit of ¥75 million in the previous fiscal year.」
Although the number of stores carrying disinfecting and deodorizing products increased, the household pharmaceuticals and other products sales business posted lower revenue due to a decline in beverage sales and swung from a profit in the previous fiscal year to a segment loss. - FY2018-Q3AdvancedAnnual report
「Sales and shipments of the disinfecting and deodorizing products "Quick Shield Air Mask" and "Quick Shield Pocket" also began at major mass retailers, drugstores and other outlets.」
The company describes specific progress in the start of sales and shipments of disinfecting and deodorizing products at major mass retailers, drugstores and other outlets. - FY2018-Q1AdvancedAnnual report
「In the wholesale segment, wholesale sales to 仙台中京医薬品 and 栃木中京医薬品, with which the company newly concluded franchise agreements, have increased.」
Wholesale sales to new franchise partners increased, representing specific progress toward developing the Wholesale Division into a core business. - FY2017RestatedAnnual report
「In the Life Care Business (the wholesale division of the household pharmaceuticals and other products sales business), sales of beverages and other products for the general market, which had been the division's mainstay, expanded, while awareness of products related to "Quick Shield Air Mask" also increased. We will establish this as a new core business.」
The company continues to pursue a policy of establishing the Wholesale Division as a new core business. - FY2017-Q3RestatedAnnual report
「In the Life Care Business (the wholesale division of the household pharmaceuticals and other products sales business), sales of beverages and other products for the general market, which had been the division's mainstay, expanded, while awareness of products related to "Quick Shield Air Mask" also increased. We will establish this as a new core business.」
The company continues to pursue a policy of establishing the Wholesale Division as a new core business. - FY2017-Q2AdvancedAnnual report
「For products related to disinfecting and deodorizing agents, we launched "Air Mask Pocket Spray" in April of the current fiscal year. "Quick Shield Air Mask" and "Quick Shield Pocket" also became regular products at major mass retailers, drugstores and other outlets, with full-scale sales and shipments beginning in September.」
Specific progress includes the launch of new products and their establishment as regular offerings, followed by the start of full-scale sales and shipments in September. - FY2017-Q1AdvancedAnnual report
「In the Wholesale Division, we focused on sales activities centered on beverages such as hydrogen water. For products related to disinfecting and deodorizing agents, we launched "Air Mask Pocket Spray" in April of the current fiscal year. "Quick Shield Air Mask" and "Quick Shield Pocket" also became regular products at major mass retailers, drugstores and other outlets.」
The company describes specific progress, including a new product launch and the products becoming regular offerings at major retail formats, in addition to its focus on beverage sales. - FY2016First statedAnnual report
「Sales of beverages and other products for the general market, which had been the division's mainstay, expanded, while awareness of products related to "Quick Shield Air Mask" also increased. We will establish this as a new core business.」
The company has positioned the Wholesale Division for development into a core business by expanding beverages and other products for the general market, as well as products related to disinfecting and deodorizing agents.